Psychologists in Kendall Park, NJ Accepting Medicare
4 Psychologists found. Showing 1 - 4
 Monika Kushwaha Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 3176 State Route 27 Ste 2b, Kendall Park, NJ 08824 Phone: 732-786-3829 Fax: 732-702-6018 |
 Dr. John Hans Rathauser, PH.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 3270 State Route 27, Suite 1100, Kendall Park, NJ 08824 Phone: 732-297-5557 |
Dr. Patricia M. Brady, ED.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 3270 State Highway 27, Kendall Park, NJ 08824 Phone: 732-821-3223 |
Carlton Thomas James, PH. D., PSY. D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 3186 State Route 27, Suite 106, Kendall Park, NJ 08824 Phone: 609-306-1533 |
News Archive
KCI receives reimbursement status for V.A.C.Via Negative Pressure Wound Therapy System
Kinetic Concepts, Inc. today announced that its groundbreaking V.A.C.Via Negative Pressure Wound Therapy System has been granted reimbursement status and will be listed on the U.K. Drug Tariff beginning August 1, 2011.
Transgender people have difficult time in finding a health care setting
Transgender people who are also racial and ethnic minorities have a difficult time finding a health care setting where all aspects of their identity are welcome, understood and addressed.
Public-private partnerships can help advance global health goals
"Three people die every minute from tuberculosis - a treatable and largely preventable disease. Resistant forms continue to thrive, and increased travel makes the global threat very real. We face a public health emergency," Vince Forlenza, chair, CEO, and president of the medical technology firm Becton, Dickinson and Company, writes in the Harvard Business Review Blog Network.
U.S. beverage industry praised for helping in childhood obesity battle
The American Beverage Association (ABA) has approved a policy aimed at limiting the sale of soft drinks in school vending machines as the nation fights obesity.
Synta Pharmaceuticals announces pricing of public offering of shares
Synta Pharmaceuticals Corp., a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced the pricing of an underwritten public offering of 5,555,556 shares of its common stock at a price to the public of $4.50 per share for gross proceeds of approximately $25 million.
› Verified 4 days ago
Dentists
Pharmacists
Clinical Social Workers
Counselors
Psychologists
Occupational Therapists